Search results
Results from the WOW.Com Content Network
Linezolid is a member of the oxazolidinone class of medications. [10] Linezolid was discovered in the mid-1990s, and was approved for commercial use in 2000. [16] [17] It is on the World Health Organization's List of Essential Medicines. [18] The World Health Organization classifies linezolid as critically important for human medicine. [19]
Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines. . Released in beta in November 2004, the Google Scholar index includes peer-reviewed online academic journals and books, conference papers, theses and dissertations, preprints, abstracts, technical reports, and other ...
Linezolid (Zyvox), which is available for intravenous administration and also has the advantage of having excellent oral bioavailability. Posizolid , which appears to have excellent, targeted bactericidal activity against all common gram-positive bacteria, regardless of resistance to other classes of antibiotics.
Journal for the Education of the Gifted; Journal of Early Intervention; Journal of Learning Disabilities; Journal of Research in Special Educational Needs; Journal of Special Education and Rehabilitation; Learning Disability Quarterly; Remedial and Special Education; Research and Practice for Persons with Severe Disabilities
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Education is a quarterly peer-reviewed academic journal covering education. It was established in 1880 by the New England Publishing Company of Boston. [ 1 ] The journal is edited by Phil Feldman and is currently published by Project Innovation, a publisher that was on Beall's list before it was taken down in 2017.
Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
Action Research is a quarterly peer-reviewed academic journal that covers the field of action research. The journal was established in 2003 and is published by SAGE Publications . The editor-in-chief is Hilary Bradbury ( AR+ Foundation ).